 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: March 2026
Volume 11 | Issue 3
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 11
Issue Published : 118
Article Submitted : 21527
Article Published : 8515
Total Authors : 22403
Total Reviewer : 805
Total Countries : 159
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A prospective study on adverse events and medication errors associated with chemotherapeutic treatment at an inpatient department in a tertiary care hospital |
| Authors Name: | Sharon Susan Raj , SHIBI MARY THOMAS , Blessy. K. George |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_184963
|
| Published Paper Id: | IJRTI2212111 |
| Published In: | Volume 7 Issue 12, December-2022 |
| DOI: | |
| Abstract: | Background: Morbidity due to medical errors is one of the leading risks to the world's health. In the context of an unstable environment as well as hereditary evolution, tumors become a constant threat in everyday life. Chemotherapeutic agents discovered as a hope in the journey against tumors often come with associated side effects. Taking our view through the pattern of side effects seen along with the most commonly prescribed chemotherapeutic agents and the type of errors that occur at an oncology setup in the hospital would help the clinicians and other health care workers to have better knowledge and patient safety. Objectives: Assessment of side effects with commonly prescribed chemotherapeutic agents was the primary objective, whereas the medication safety associated with the latter was taken as the secondary objective. Method: It was a prospective observational cross-sectional study in which 134 patients’ prescriptions were analyzed to assess the chemotherapeutic side effects as well as the medication errors while handling the chemotherapeutic agents in a hospital setup. Results: The study was conducted on 134 patients and there were around 27 types of tumors that were treated. Around 80% of the population belongs to the age group of 20 - 65 years and breast cancer is the top most treated tumor, 68.6% of the sample population was women. There were 10 classes of chemotherapeutic agents used and Cisplatin stands as the highest used drug. Upon checking the side effects, nausea, vomiting, and diarrhea were seen in the majority of the sample population. On the other hand, there were 34 prescriptions and 16 administration errors seen during the treatment period. Conclusion: The study on adverse effects of chemotherapeutic agents has been studied along with the type of prescription and administration errors that occur during the treatment. The study saw various side effects that the patient undergoes in the course of the treatment. It also shows a torch towards the possibility of different types of medication errors that can lead to worse outcomes or increased hospital stay and financial burden to the patients. This study becomes highly significant when seen in the context of a developing country. |
| Keywords: | medication safety, chemotherapeutic drugs, adverse effects, error in prescription, administration errors |
| Cite Article: | "A prospective study on adverse events and medication errors associated with chemotherapeutic treatment at an inpatient department in a tertiary care hospital", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 12, page no.727 - 738, December-2022, Available :http://www.ijrti.org/papers/IJRTI2212111.pdf |
| Downloads: | 000205282 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2212111
Registration ID:184963
Published In: Volume 7 Issue 12, December-2022
DOI (Digital Object Identifier):
Page No: 727 - 738 Country: Kollam, kerala, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2212111 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2212111 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2026 - All Rights Reserved - IJRTI | |||